Ambovex® as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial

Por Salama H, Ahmad H, Elchagea I, Zekri AR, Medhat E, Bahnassy A, Lange M, Rabbat M, de la Torre AN, Punamiya P
Publicado em 2015-06-01